Delayed Graft Function Is Reduced With Antithymocyte Globulin Induction in Pediatric Kidney Transplantation

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2373-2375

  Vilalta, R ^a   Lara, E ^a   Madrid, A ^a   Chocron, S ^a   Vazquez, A ^a   Casquero, A ^a   Nieto, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTOPENIA; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTION; PEDIATRIC SURGERY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CADAVER; CHILD; CHILD, PRESCHOOL; DELAYED GRAFT FUNCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; TACROLIMUS; TISSUE DONORS;

EID: 68949209720     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.037     Document Type: Article

References (8)

1. Killonen L.E., Eklund B.H., Pesonen E.J., et al. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. Transplantation 84 (2007) 75
2. Ellis D., Shapiro R., Moritz M., et al. Transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation 83 (2007) 1563
3. Choileain N.N., Macconmara M., Zang Y., et al. Enhanced regulatory T-cell activity is an element of the host response to injury. J Immunol 176 (2006) 225
4. Murphy T.J., Choleain N.N., and Lederer J.A. CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 174 (2005) 2957
5. Huang E., Cho Y.W., Hayashi R., et al. Alemtuzumab induction in deceased donor kidney transplantation. Transplantation 84 (2007) 821
6. Murphy T.J., Paterson H.M., Kriynovich S., et al. Linking the "two-hit" response followiung injury to enhanced TLR4 reactivity. J Leuc Biol 77 (2005) 16
7. Samsel R., Rowinski W., Chmura A., et al. Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renalt transplantation: preliminary results. Transplant Proc 33 (2001) 2952
8. Martins L., Fonseca I., Almeida M., et al. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival. Transplant Proc 37 (2005) 2755